MMedication Read More The Latest Ozempic Side Effect? It May Make You Less ViolentJune 18, 2026 Topline GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent criminal behavior among current users,…
HHealthcare Read More Novo Nordisk comeback stirs as Wegovy pill wins UK approvalJune 13, 2026 The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another…
MMedication Read More Generic semaglutide market shows signs of excess inventory bulge | Industry NewsJune 12, 2026 Pharmarack data indicates elevated stock levels across several recently launched brands amid slower-than-expected liquidation in the trade…
HHealthcare Read More Novo Nordisk shares retreat after ADA conference updates fail to excite investors (NVO)June 8, 2026 chart down red arrow NEW SIZE ©Shutterstock Novo Nordisk (NYSE:NVO) shares fell 3% on Monday as investors digested…
MMedication Read More Can Wegovy Pill’s Rapid Uptake Give Novo Nordisk an Edge Over LLY?June 8, 2026 Novo Nordisk NVO remains one of the dominant players in the rapidly expanding obesity treatment market. The company markets…
MMedication Read More Why Canadians can now get cheaper generic OzempicJune 6, 2026 Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to help reverse her…
HHealthcare Read More Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 SuccessJune 6, 2026 The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the…
MMedication Read More Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily CoveredJune 2, 2026 Eli Lilly’s Foundayo weight loss oral pill competes against Novo Nordisk’s oral Wegovy. (Photo by: Michael Siluk/UCG/Universal Images…
MMedication Read More Brazil approves first generic semaglutide pen after Ozempic patent expiryMay 26, 2026 SAO PAULO, May 26 (Reuters) – Brazil’s health regulator Anvisa said on Tuesday it had approved EMS’s Ozivy,…
MMedication Read More How GLP-1s are more than just weight-loss wonders – but not without riskMay 23, 2026 Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
MMedication Read More LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance CaseMay 22, 2026 Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
MMedication Read More Canadians can now get digital prescriptions for ‘generic Ozempic’May 21, 2026 Telehealth provider Hims & Hers Health Inc. announced Thursday the availability of generic semaglutide through its platform, allowing…